Long-term outcomes after cytoreductive nephrectomy and thrombectomy of patients with metastatic renal cell carcinoma with venous tumor thrombus: a retrospective study from a large Chinese center

BACKGROUND: Targeted therapy combined with immunotherapy is the current first-line treatment for metastatic renal cell carcinoma (mRCC), but patients with tumor thrombus (TT) may suffer from lower limb edema or even sudden cardiac death, so the purpose of this study is to investigate the efficacy an...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Kewei, Liu, Zhuo, Li, Yuxuan, Zhao, Xun, Zhang, Yu, Bi, Hai, Wang, Guoliang, Liu, Cheng, Tian, Xiaojun, Zhang, Hongxian, Ma, Lulin, Zhang, Shudong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10246180/
https://www.ncbi.nlm.nih.gov/pubmed/37280590
http://dx.doi.org/10.1186/s12957-023-03048-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10246180/
https://www.ncbi.nlm.nih.gov/pubmed/37280590
http://dx.doi.org/10.1186/s12957-023-03048-z

Ejemplares similares